Mail to a Friend
Rate      

UChicago scientists explore saliva testing for COVID-19



2020-08-10 03:17:09 Health and Fitness

130


“It’s like having your brain tickled through your nose.” “Longest five seconds of my life.” “Not for the faint-hearted.” The swab to take the COVID-19 test, known as a nasopharyngeal swab, is not a pleasant experience. To obtain a thorough sample, health care workers need to scrape deep in the nasal cavity. More concerningly, the swab sticks themselves fell in short supply during the early stages of the COVID-19 crisis in the U.S., limiting the number of tests providers could run.

But it’s increasingly clear that the virus is also detectable in saliva. A team of University of Chicago scientists is exploring whether a saliva-based test for COVID-19 may be an effective alternative to the nasopharyngeal swab.

COVID-19 is primarily an upper respiratory disease, settling in the nose and sinuses, so the long, thin nasopharyngeal swabs become the primary method for testing. After health care workers take the sample, they load it into a machine that extracts genetic material from the virus and copies it. If there are COVID-19 genes in the mix, they get labeled with a light-up tag.

The machines running this test across the country are almost all based on a particular technique called qPCR, which has been in use for many years. But scientists are also testing a newer detection system called droplet-digital PCR or ddPCR. In theory, the new system could be more sensitive than qPCR, able to get a positive reading even if there are lower amounts of the virus in the sample. “It could provide clinicians with a quantitative measure of how much virus is present, beyond a simple yes or no,” said Prof. Nishant Agrawal, a UChicago surgeon-scientist and an investigator on the study who has been working on digital PCR and saliva for over a decade.

“It’s possible that people who have the virus but don’t show symptoms, may have a smaller amount of virus that wouldn’t show up on tests,” said Assoc. Prof. Jeremy Segal, a UChicago pathologist and an investigator on the study. “If they’re still able to spread the virus, being able to detect those people would be very important. We just don’t know yet—there are so many unknowns still.”

As the pandemic ramped up in Illinois in late March and early April, Segal and Asst. Prof. Evgeny Izumchenko, a University of Chicago Medicine geneticist, teamed up with Assoc. Prof. Savas Tay’s lab at the Pritzker School of Molecular Engineering to test out ddPCR methods for detecting COVID-19.

Because ddPCR is newer and fully automated testing is still being developed, scientists have to carry out the steps by hand. Because they were already using the ddPCR system on nasopharyngeal swabs, they decided to also try using saliva.

“The beauty of it is that it’s less invasive, and you could allow people to collect their own samples; everyone knows how to spit,” said Izumchenko.

To solicit patients to volunteer for the trial, the researchers set up an additional booth at UChicago Medicine’s curbside testing for COVID-19. After UChicago Medicine workers took their samples for the standard nasopharyngeal swab run by the hospital diagnostics lab, the volunteers would go over to the booth, get a second nasopharyngeal swab and spit in a tube for the trial. That way researchers could compare the two methods directly: Investigators run the ddPCR tests on both the nasal swabs and saliva samples at Tay’s lab, and the hospital runs the standard qPCR test.

User :- Deepika Girdhar

Email :-girdhar.deepika756@gmail.com

Mobile:- + 91 9643470449


forpressrelease



Related Post

Advertisement

BuyEssaysCheap.com - affordable writing help
There is no better press release writing company as 123 term papers.
Buy 100% high-quality replica watches with a 2-year warranty and free ground shipping!
Online assignment help by Copycrafter will free you from any academic issues
On-demand assignment help - find an assignment experts in 3 steps.